DE148208C - - Google Patents
Info
- Publication number
- DE148208C DE148208C DE1903148208D DE148208DA DE148208C DE 148208 C DE148208 C DE 148208C DE 1903148208 D DE1903148208 D DE 1903148208D DE 148208D A DE148208D A DE 148208DA DE 148208 C DE148208 C DE 148208C
- Authority
- DE
- Germany
- Prior art keywords
- monoformyl
- dioxypyrimidine
- diamido
- dimethyl
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000001035 methylating effect Effects 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- -1 iodomethyl Chemical group 0.000 description 4
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 3
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000003513 alkali Substances 0.000 description 2
- 239000002168 alkylating agent Substances 0.000 description 2
- 229940100198 alkylating agent Drugs 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 229960000278 theophylline Drugs 0.000 description 2
- 101000952234 Homo sapiens Sphingolipid delta(4)-desaturase DES1 Proteins 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 102100037416 Sphingolipid delta(4)-desaturase DES1 Human genes 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 125000001188 haloalkyl group Chemical group 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT17703D AT17703B (de) | 1903-02-06 | 1903-06-27 | Verfahren zur Darstellung von Monoformyl-1,3-dimethyl-4,5-diamido-2,6-dioxypyrimidin. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE148208C true DE148208C (enrdf_load_stackoverflow) |
Family
ID=415319
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE1903148208D Expired - Lifetime DE148208C (enrdf_load_stackoverflow) | 1903-02-06 | 1903-02-06 |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE148208C (enrdf_load_stackoverflow) |
-
1903
- 1903-02-06 DE DE1903148208D patent/DE148208C/de not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1059459B (de) | Verfahren zur Herstellung des therapeutisch wertvollen 3-Sulfanilamido-5-methylisoxazols | |
| DE148208C (enrdf_load_stackoverflow) | ||
| CH364506A (de) | Verfahren zur Herstellung des therapeutisch wirksamen 3-Sulfanilamido-5-methyl-isoxazols | |
| DE1147232B (de) | Verfahren zur Herstellung von 2, 5-Di-[benzimidazyl-(2')]-furanverbindungen | |
| DE933340C (de) | Verfahren zur Herstellung von therapeutisch wertvollen Mitteln der p-Aminobenzolsulfonamid-Reihe | |
| DE971656C (de) | Verfahren zur Herstellung von Abkoemmlingen von Sulfonamiden der Pyrimidinreihe | |
| DE907892C (de) | Verfahren zur Herstellung von Sulfonaten | |
| DE896492C (de) | Verfahren zur Herstellung von 2-Halogenarylamino-4-amino-1, 3, 5-triazinderivaten | |
| DE503031C (de) | Verfahren zur Darstellung der N-Oxyaethylderivate von Kernsubstitutionsprodukten des -Amino-1-oxybenzols | |
| DE158592C (enrdf_load_stackoverflow) | ||
| DE838141C (de) | Verfahren zur Herstellung von 2-Chlorpyrimiddn | |
| DE972507C (de) | Verfahren zur Herstellung von Abkoemmlingen von Sulfonamiden der Pyrimidinreihe | |
| DE213155C (enrdf_load_stackoverflow) | ||
| DE156055C (enrdf_load_stackoverflow) | ||
| DE864555C (de) | Verfahren zur Herstellung von 2, 4-Diamino-5-aryloxypyrimidinen | |
| DE236046C (enrdf_load_stackoverflow) | ||
| DE848043C (de) | Verfahren zur Herstellung von Formylverbindungen des 2,6-Dioxy-4,5-diaminopyrimidinsund seiner Methylderivate | |
| DE870552C (de) | Verfahren zur Herstellung neuer Amidinsalze | |
| CH215293A (de) | Verfahren zur Herstellung eines Harnstoffderivates. | |
| DE964495C (de) | Verfahren zur Herstellung eines neuen Thiosemicarbazids | |
| DE194935C (enrdf_load_stackoverflow) | ||
| AT151654B (de) | Verfahren zur Darstellung trisubstituierter Barbitursäuren. | |
| DE967224C (de) | Verfahren zur Herstellung von 4-(p-Aminobenzolsulfonamido)-pyrimidinabkoemmlingen | |
| DE511466C (de) | Verfahren zur Darstellung von aminosubstituierten Chinolinverbindungen | |
| DE486772C (de) | Verfahren zur Darstellung der N-Oxyaethylderivate des 4-Amino-1-oxybenzols |